The impact of second-line agents on patients’ health-related quality of life in the treatment for non-small cell lung cancer: a systematic review

Arijit Ganguli(Astellas Pharma (United States)), Saurabh Ray(New York University Abu Dhabi), John A. Carter(Pharmerit (United States)), Marc Botteman(Pharmerit (United States)), P. Wiegand(Pharmerit (United States)), Xīn Gào(Qingdao University)

Quality of Life Research

July 17, 2012

Cited by 13

|Nature Genetics|2000|1.4k

|The Journal of Cell Biology|2009|406

|Circulation Research|2009|366

|Journal of the National Comprehensive Cancer Network|2024|289

|Journal of Gastrointestinal Surgery|2014|271

Related Papers